Helix Miss, published in an international journal on the results of Phase III clinical trials in the US [Google translation]

Engensis (donaperminogene seltoplasmid) - Beijing Northland, Reyon Pharma, Helixmith

https://www.etoday.co.kr/news/view/1986846

Jan 21, 2021